LONDON (AP) — Oxford University announced Saturday it was resuming a trial for a coronavirus vaccine it is developing with pharmaceutical company AstraZeneca, a move that comes days after the study was suspended following a reported side-effect in a U.K. patient. In a statement, the university confirmed the restart across all of its U.K. clinical…
Source: NY Post click here for more…